ArticleSichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition2025
[Predictive Performance of Routine Blood Test Parameters for the Severity of Brain Damage in Patients With Acute Cerebral Hemorrhage in High-Altitude Regions].
Article in Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the predictive value of changes in various indicators of routine blood tests for the severity of brain damage in patients with acute cerebral hemorrhage (ACH) in high-altitude regions. Methods: A retrospective analysis was conducted using data from 249 inpatients diagnosed with ACH at a hospital in Xizang. Patient data, including demographic information and results of routine blood tests, were collected. Based on their Glasgow Coma Scale (GCS) scores, the patients were divided into 2 groups, a mild brain damage group (GCS ≥ 13 points) and a moderate-to-severe brain damage group (GCS ≤ 12 points). Demographic information and laboratory test results were compared between the two groups. Binary logistic regression analysis was performed to examine the relationship between indicators of routine blood tests and the severity of brain damage, and key indicators were identified. The receiver operating characteristic (ROC) curve analysis was used to evaluate the predictive performance of key indicators in various combinations for the severity of brain injury in ACH patients. Results: The moderate-to-severe group had a higher proportion of high-altitude residents, as well as elevated levels of white blood cells (WBC), neutrophils (N), neutrophil-to-lymphocyte ratio (NLR), systemic inflammatory index (SII), neutrophil-to-platelet ratio (NPR), and C-reactive protein (CRP)-to-lymphocyte ratio (CLR), compared to the mild group. On the other hand, the levels of lymphocytes (L), platelets (PLT), and platelet-to-albumin ratio (PAR) in the moderate-to-severe group were lower than those in the mild group. Binary logistic regression analysis showed that WBC (OR = 1.221, 95% CI: 1.127-1.322), CRP (OR = 1.019, 95% CI: 1.004-1.033), CRP-to-albumin ratio (CAR) (OR = 1.845, 95% CI: 1.137-2.996), and CLR (OR = 1.018, 95% CI: 1.005-1.030) were positively associated with moderate-to-severe brain damage, and that their elevated levels were associated with an increase in risk by the corresponding folds. PAR (OR = 0.845, 95% CI: 0.721-0.990) was negatively correlated with moderate-to-severe brain damage, with an increase resulting in a reduction of risk by 0.845 times. ROC curve analysis showed that, in the mild group, the combined AUC for WBC + CRP was 0.689 (optimal cutoff value 0.19, specificity 0.776, 95% CI: 0.624-0.755) ; the PAR + CAR + CLR combination (CAR was not significant, Conclusion: The indicator combinations of WBC + CRP, PAR + CLR, and WBC + PAR + CLR exhibit significant value for predicting the severity of brain injury in ACH patients and may serve as potential predictive tools for the severity of brain damage in patients with acute cerebral hemorrhage in high-altitude regions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.